BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li Z, Qi F, Li F. Establishment of a Gene Signature to Predict Prognosis for Patients with Lung Adenocarcinoma. Int J Mol Sci 2020;21:E8479. [PMID: 33187219 DOI: 10.3390/ijms21228479] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Gu J, Guo Y, Du J, Kong L, Deng J, Tao B, Li H, Jin C, Fu D, Li J. CDCA8/SNAI2 Complex Activates CD44 to Promote Proliferation and Invasion of Pancreatic Ductal Adenocarcinoma. Cancers 2022;14:5434. [DOI: 10.3390/cancers14215434] [Reference Citation Analysis]
2 Zhang Q, Wang Y, Xue F, Singh K. ASPM, CDC20, DLGAP5, BUB1B, CDCA8, and NCAPG May Serve as Diagnostic and Prognostic Biomarkers in Endometrial Carcinoma. Genetics Research 2022;2022:1-18. [DOI: 10.1155/2022/3217248] [Reference Citation Analysis]
3 Wu G, Wang Y, Wan Y. Establishing an 8-gene immune prognostic model based on TP53 status for lung adenocarcinoma. J Clin Lab Anal 2022;36:e24538. [PMID: 35689561 DOI: 10.1002/jcla.24538] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Tang W, Lu Q, Zhu J, Zheng X, Fang N, Ji S, Lu F. Identification of a Prognostic Signature Composed of GPI, IL22RA1, CCT6A and SPOCK1 for Lung Adenocarcinoma Based on Bioinformatic Analysis of lncRNA-Mediated ceRNA Network and Sample Validation. Front Oncol 2022;12:844691. [PMID: 35433415 DOI: 10.3389/fonc.2022.844691] [Reference Citation Analysis]
5 Liu P, Li H, Liao C, Tang Y, Li M, Wang Z, Wu Q, Zhou Y. Identification of key genes and biological pathways in Chinese lung cancer population using bioinformatics analysis. PeerJ 2022;10:e12731. [PMID: 35178291 DOI: 10.7717/peerj.12731] [Reference Citation Analysis]
6 Li F, Wan B, He X, Li X, Wang F. Identification of Novel Subtypes in Lung Adenocarcinoma: Evidence from Gene Set Variation Analysis in Tumor and Adjacent Nontumor Samples. Disease Markers 2022;2022:1-10. [DOI: 10.1155/2022/2602812] [Reference Citation Analysis]
7 Li Z, Fei H, Lei S, Hao F, Yang L, Li W, Zhang L, Fei R. Identification of HMMR as a prognostic biomarker for patients with lung adenocarcinoma via integrated bioinformatics analysis. PeerJ 2021;9:e12624. [PMID: 35036134 DOI: 10.7717/peerj.12624] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Liu L, Xu K, Zhou Y. Development of a novel embryonic germline gene-related prognostic model of lung adenocarcinoma. PeerJ 2021;9:e12257. [PMID: 34721973 DOI: 10.7717/peerj.12257] [Reference Citation Analysis]
9 Chen H, Shen W, Ni S, Sang M, Wu S, Mu Y, Liu K, Li N, Zhu L, Xu G. Construction of an immune-related lncRNA signature as a novel prognosis biomarker for LUAD. Aging (Albany NY) 2021;13:20684-97. [PMID: 34438369 DOI: 10.18632/aging.203455] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
10 Wang W, Liu W. PCLasso: a protein complex-based, group lasso-Cox model for accurate prognosis and risk protein complex discovery. Brief Bioinform 2021:bbab212. [PMID: 34086850 DOI: 10.1093/bib/bbab212] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
11 Wang J, Liang J, Li H, Han J, Jiang J, Li Y, Feng Z, Zhao R, Tian H. Oncogenic role of abnormal spindle‑like microcephaly‑associated protein in lung adenocarcinoma. Int J Oncol 2021;58:23. [PMID: 33786609 DOI: 10.3892/ijo.2021.5203] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Zengin T, Önal-Süzek T. Comprehensive Profiling of Genomic and Transcriptomic Differences between Risk Groups of Lung Adenocarcinoma and Lung Squamous Cell Carcinoma. J Pers Med 2021;11:154. [PMID: 33672117 DOI: 10.3390/jpm11020154] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]